Saturday, June 20, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 404 of 1,261
  1. US 10744104

    Neprilysin inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Aug 18, 2020 · Expires Aug 13, 2040

    granted
  2. US 10744232

    Antimicrobial catheters

    The Board of Regents of the University of Texas System · Granted Aug 18, 2020 · Expires Aug 13, 2040

    granted
  3. US 10745701

    Methods of identifying and treating poor-prognosis cancers

    THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Aug 18, 2020 · Expires Aug 13, 2040

    granted
  4. US 10745397

    1-Substituted 1,2,3,4-tetrahydro-1,7-naphthyridin-8-amine derivatives and their use as EP4 receptor antagonists

    Takeda Pharmaceutical Company Limited · Granted Aug 18, 2020 · Expires Aug 13, 2040

    granted
  5. US 10745474

    Methods of treating inflammation associated airway diseases and viral infections

    The Board of Regents of the University of Texas System · Granted Aug 18, 2020 · Expires Aug 13, 2040

    granted
  6. US 10743542

    Preparation method and use of an atomic-state fluid iodine and its derived nano-iodine

    CHINESE ACADEMY OF AGRICULTURAL ENGINEERING PLANNING & DESIGN · Granted Aug 18, 2020 · Expires Aug 13, 2040

    granted
  7. US 10744103

    Methods and compositions for treating conditions associated with an abnormal inflammatory responses

    First Wave Bio, Inc. · Granted Aug 18, 2020 · Expires Aug 13, 2040

    granted
  8. US 10744154

    Galactose-pronged polysaccharides in a formulation for antifibrotic therapies

    GALECTIN THERAPEUTICS, INC. · Granted Aug 18, 2020 · Expires Aug 13, 2040

    granted
  9. US 10744116

    Detection and treatment of anti-PD-1 therapy resistant metastatic melanomas

    The Regents of the University of California · Granted Aug 18, 2020 · Expires Aug 13, 2040

    granted
  10. US 10744152

    Application of Asarum total polysaccharides in preparation of medicine for treating cough

    THE FIRST AFFILIATTED HOSPITAL OF GUANGZHOU MEDICAL UNIVERSITY · Granted Aug 18, 2020 · Expires Aug 13, 2040

    granted
  11. US 10744173

    Traditional Chinese medicine compositions for alleviating stress

    INFINITUS (CHINA) COMPANY LTD. · Granted Aug 18, 2020 · Expires Aug 13, 2040

    granted
  12. US 10744193

    Immunogenic RSV polypeptides

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 18, 2020 · Expires Aug 13, 2040

    granted
  13. US 10745352

    Dual function molecules for histone deacetylase inhibition and ataxia telangiectasia mutated activation and methods of use thereof

    Shuttle Pharmaceuticals, Inc. · Granted Aug 18, 2020 · Expires Aug 13, 2040

    granted
  14. US 10745366

    Therapeutic compounds

    ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Aug 18, 2020 · Expires Aug 13, 2040

    granted
  15. US 10745392

    Benzenesulfonamide compounds and their use as therapeutic agents

    Xenon Pharmaceuticals Inc. · Granted Aug 18, 2020 · Expires Aug 13, 2040

    granted
  16. US 10745394

    8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists

    Theravance Biopharma R&D IP, LLC · Granted Aug 18, 2020 · Expires Aug 13, 2040

    granted
  17. US 10745453

    Compositions and methods for enhancing visual function

    The Regents of the University of California · Granted Aug 18, 2020 · Expires Aug 13, 2040

    granted
  18. US 10745464

    Aldehyde tags, uses thereof in site-specific protein modification

    The Regents of the University of California · Granted Aug 18, 2020 · Expires Aug 13, 2040

    granted
  19. US 10745413

    Commercially viable synthesis of cantharidin and bioactive cantharidin derivatives

    Verrica Pharmaceuticals Inc. · Granted Aug 18, 2020 · Expires Aug 13, 2040

    granted
  20. US 10745416

    Macrocyclic compounds for treating disease

    TURNING POINT THERAPEUTICS, INC. · Granted Aug 18, 2020 · Expires Aug 13, 2040

    granted
  21. US 10745405

    Glucuronide prodrugs of Janus kinase inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Aug 18, 2020 · Expires Aug 13, 2040

    granted
  22. US 10745420

    Tetrahydropyrido[4,3-d]pyrimidine inhibitors of ATR kinase

    The Board of Regents of the University of Texas System · Granted Aug 18, 2020 · Expires Aug 13, 2040

    granted
  23. US 10745466

    Type III secretion system targeting molecules

    Inhibrx, Inc. · Granted Aug 18, 2020 · Expires Aug 13, 2040

    granted
  24. US 10745475

    Antibodies neutralizing GM-CSF for use in the treatment of rheumatoid arthritis or as analgesics

    TAKEDA GMBH · Granted Aug 18, 2020 · Expires Aug 13, 2040

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.